The Diagnosis of Fungal Neglected Tropical Diseases (Fungal NTDs) and the Role of Investigation and Laboratory Tests: An Expert Consensus Report.

chromoblastomycosis fungal NTDs integrated approaches laboratory diagnosis mycetoma sporotrichosis

Journal

Tropical medicine and infectious disease
ISSN: 2414-6366
Titre abrégé: Trop Med Infect Dis
Pays: Switzerland
ID NLM: 101709042

Informations de publication

Date de publication:
24 Sep 2019
Historique:
received: 25 07 2019
revised: 18 08 2019
accepted: 06 09 2019
entrez: 27 9 2019
pubmed: 27 9 2019
medline: 27 9 2019
Statut: epublish

Résumé

The diagnosis of fungal Neglected Tropical Diseases (NTD) is primarily based on initial visual recognition of a suspected case followed by confirmatory laboratory testing, which is often limited to specialized facilities. Although molecular and serodiagnostic tools have advanced, a substantial gap remains between the desirable and the practical in endemic settings. To explore this issue further, we conducted a survey of subject matter experts on the optimal diagnostic methods sufficient to initiate treatment in well-equipped versus basic healthcare settings, as well as optimal sampling methods, for three fungal NTDs: mycetoma, chromoblastomycosis, and sporotrichosis. A survey of 23 centres found consensus on the key role of semi-invasive sampling methods such as biopsy diagnosis as compared with swabs or impression smears, and on the importance of histopathology, direct microscopy, and culture for mycetoma and chromoblastomycosis confirmation in well-equipped laboratories. In basic healthcare settings, direct microscopy combined with clinical signs were reported to be the most useful diagnostic indicators to prompt referral for treatment. The survey identified that the diagnosis of sporotrichosis is the most problematic with poor sensitivity across the most widely available laboratory tests except fungal culture, highlighting the need to improve mycological diagnostic capacity and to develop innovative diagnostic solutions. Fungal microscopy and culture are now recognized as WHO essential diagnostic tests and better training in their application will help improve the situation. For mycetoma and sporotrichosis, in particular, advances in identifying specific marker antigens or genomic sequences may pave the way for new laboratory-based or point-of-care tests, although this is a formidable task given the large number of different organisms that can cause fungal NTDs.

Identifiants

pubmed: 31554262
pii: tropicalmed4040122
doi: 10.3390/tropicalmed4040122
pmc: PMC6958312
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

PLoS Negl Trop Dis. 2018 May 10;12(5):e0006391
pubmed: 29746460
Med Mycol. 2017 Nov 1;55(8):851-858
pubmed: 28053146
Med Mycol J. 2016;57(3):E47-57
pubmed: 27581775
PLoS Negl Trop Dis. 2015 Dec 01;9(12):e0004190
pubmed: 26623643
Rev Soc Bras Med Trop. 2013 Jan-Feb;46(1):116-8
pubmed: 23563841
Rev Soc Bras Med Trop. 2015 Jul-Aug;48(4):504
pubmed: 26312944
Med Mycol. 2015 Jan;53(1):28-33
pubmed: 25477075
PLoS Negl Trop Dis. 2014 Oct 09;8(10):e3232
pubmed: 25299610
Skinmed. 2016 Dec 01;14(6):423-427
pubmed: 28031127
J Health Care Poor Underserved. 2016;27(3):993-1010
pubmed: 27524747
PLoS Negl Trop Dis. 2017 Apr 20;11(4):e0005509
pubmed: 28426654
J Fungi (Basel). 2018 May 23;4(2):null
pubmed: 29882883
J Fungi (Basel). 2018 May 09;4(2):null
pubmed: 29747448
Trans R Soc Trop Med Hyg. 2016 May;110(5):312-6
pubmed: 27198216
PLoS Negl Trop Dis. 2017 Jan 19;11(1):e0005136
pubmed: 28103250
Med Mycol. 2018 Apr 1;56(suppl_1):153-164
pubmed: 28992217
PLoS Negl Trop Dis. 2015 Aug 25;9(8):e0004016
pubmed: 26305691
Dermatol Pract Concept. 2017 Oct 31;7(4):23-24
pubmed: 29214105
Trans R Soc Trop Med Hyg. 2016 Dec 1;110(12):679-680
pubmed: 28938054
Diagn Microbiol Infect Dis. 2014 Jul;79(3):328-30
pubmed: 24827145
J Clin Microbiol. 2017 Aug;55(8):2521-2528
pubmed: 28592546
Trans R Soc Trop Med Hyg. 2012 Dec;106(12):738-42
pubmed: 22981317
Int J Dermatol. 2019 Feb;58(2):231-232
pubmed: 30074613
An Bras Dermatol. 2014 Sep-Oct;89(5):832-3
pubmed: 25184931
J Eur Acad Dermatol Venereol. 2019 Jan;33(1):e33-e35
pubmed: 29953691
PLoS Negl Trop Dis. 2016 Nov 28;10(11):e0005102
pubmed: 27893750
Clin Microbiol Rev. 2017 Jan;30(1):233-276
pubmed: 27856522
Lancet. 2018 May 12;391(10133):1927-1938
pubmed: 29550029
PLoS Negl Trop Dis. 2013 Nov 07;7(11):e2550
pubmed: 24244780
J Fungi (Basel). 2018 May 09;4(2):null
pubmed: 29747377
Mycoses. 2011 Sep;54(5):e577-82
pubmed: 21910759
Trends Parasitol. 2016 Nov;32(11):843-854
pubmed: 27638231
PLoS Negl Trop Dis. 2017 Aug 24;11(8):e0005638
pubmed: 28837657
J Eur Acad Dermatol Venereol. 2018 Jun;32(6):e223-e224
pubmed: 29224242

Auteurs

Roderick Hay (R)

The International Foundation for Dermatology, London W1T 5HQ, UK. roderick.hay@ifd.org.

David W Denning (DW)

The Global Fund for Fungal Infections, 1208 Geneva, Switzerland, and the University of Manchester, Manchester M13 9PL, UK. david.denning@gaffi.org.

Alexandro Bonifaz (A)

Hospital General de México, "Dr. Eduardo Liceaga", CP 06720, Mexico. a_bonifaz@yahoo.com.mx.

Flavio Queiroz-Telles (F)

Department of Public Health, Hospital de Clinicas, Federal University of Parana, 80060-900 Curriba, Parana, Brazil. queiroz.telles@uol.com.br.

Karlyn Beer (K)

Centers for Disease Control and Prevention, Atlanta, GA 30329, USA. ydh7@cdc.gov.

Beatriz Bustamante (B)

Tropical Medicine, Infectious Diseases and Dermatology Department at the Hospital Cayetano Heredia, Lima 15102, Peru. ana.bustamante@upch.pe.

Arunaloke Chakrabarti (A)

Postgraduate Institute of Medical Education and Research, Chandigarh 160012, India. arunaloke@hotmail.com.

Maria de Guadalupe Chavez-Lopez (MG)

Hospital General de Acapulco, Secretaria de Salud Guerrero, C.P. 39901, Mexico. chavezg13@live.com.mx.

Tom Chiller (T)

Centers for Disease Control and Prevention, Atlanta, GA 30329, USA. tnc3@cdc.gov.

Muriel Cornet (M)

Laboratoire de Parasitologie-Mycologie, Grenoble Alpes University, CNRS, Grenoble INP, CHU Grenoble Alpes, F-38000, France. mcornet@chu-grenoble.fr.

Roberto Estrada (R)

Community Dermatology Mexico C.A., Acapulco 39850, Guerrero, Mexico. restrada_13@hotmail.com.

Guadalupe Estrada-Chavez (G)

Community Dermatology Mexico C.A., Acapulco 39850, Guerrero, Mexico.

Ahmed Fahal (A)

The Mycetoma Research Centre, Khartoum, Soba University Hospital, P.O. Box 102, Sudan. ahfahal@hotmail.com.

Beatriz L Gomez (BL)

School of Medicine and Health Sciences, Universidad del Rosario, Bogota 111211, Colombia. beatrizlgomez@hotmail.com.

Ruoyu Li (R)

Peking University First Hospital, Research Centre for Medical Mycology, Peking University, Beijing 100034, China. mycolab@126.com.

Yesholata Mahabeer (Y)

Department of Medical Microbiology, National Health Laboratory Services and School of Laboratory Medicine and Medical Sciences, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Berea, Durban 4001, South Africa. MAHAB@ukzn.ac.za.

Anisa Mosam (A)

Nelson R Mandela School of Medicine, University of Kwazulu Natal, Berea, Durban 4001, South Africa. mosama@ukzn.ac.za.

Lala Soavina Ramarozatovo (L)

Faculty of Médicine, Antananarivo B.P 375 - 101, Madagascar. lsramarozatovo@gmail.com.

Mala Rakoto Andrianarivelo (M)

Centre d'Infectiologie Charles Mérieux, Université d'Antananarivo, Antananarivo BP 4299, Madagascar. mala@cicm-madagascar.com.

Fahafahantsoa Rapelanoro Rabenja (F)

Faculty of Médicine, Antananarivo B.P 375 - 101, Madagascar. frapelanoro@yahoo.fr.

Wendy van de Sande (W)

Erasmus MC, Department of Medical Microbiology and Infectious Diseases, 3000 CA Rotterdam, The Netherlands. w.vandesande@erasmusmc.nl.

Eduard E Zijlstra (EE)

Drugs for Neglected Disease Initiative, 1202 Geneva, Switzerland. ezijlstra@dndi.org.

Classifications MeSH